Drugs / Moexipril HCl/ Hydrochlorothiazide
Follow
re-read 3 minutes ago
Moexipril HCl/ Hydrochlorothiazide
also known as
Moexipril/ Hydrochlorothiazide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00990301 | — | — | Paddock Laboratories, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Moexipril HCl/ Hydrochlorothiazide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00990301 ↗ |
| Known as | Moexipril/ Hydrochlorothiazide | “test formulation of Moexipril/ Hydrochlorothiazide 15mg/25mg tablets” NCT00990301 ↗ |